Klastersky J
Am J Med. 1986 May 30;80(5C):2-12.
It appears that the use of antibiotic combinations, especially synergistic ones, is indicated for the management of gram-negative bacillary sepsis in granulocytopenic patients. Synergism is a valuable factor in increasing the serum bactericidal activity, which is highly likely to be important for a favorable outcome in these infections. The potential side effects of antimicrobial combinations should not deter clinicians from their use. The most frequently used combinations for gram-negative bacillary infections are those involving beta-lactams and aminoglycosides. Other potentially synergistic combinations exist as well; however, the clinical experience with these combinations is limited, and, as with double beta-lactam combinations, their potential for antagonism necessitates care when using them. Besides gram-negative bacillary sepsis in granulocytopenic patients, severe staphylococcal infections might represent an indication for the use of combination therapy, especially in patients with compromised mechanisms of defense against infection.
对于粒细胞减少患者革兰氏阴性杆菌败血症的治疗,似乎使用抗生素联合用药,尤其是具有协同作用的联合用药是合适的。协同作用是提高血清杀菌活性的一个重要因素,这很可能对这些感染的良好预后至关重要。抗菌药物联合使用的潜在副作用不应阻碍临床医生使用它们。革兰氏阴性杆菌感染最常用的联合用药是涉及β-内酰胺类和氨基糖苷类的联合用药。其他潜在的协同联合用药也存在;然而,这些联合用药的临床经验有限,并且与双β-内酰胺联合用药一样,它们存在拮抗作用的可能性,使用时需要谨慎。除了粒细胞减少患者的革兰氏阴性杆菌败血症外,严重的葡萄球菌感染可能是联合治疗的一个适应证,特别是在抗感染防御机制受损的患者中。